Combo Vial: CJC-1295 no DAC/Ipamorelin (20mg vials)

Research combination: CJC-1295 no DAC/Ipamorelin Combo Vial.
Research focus: GHRH-receptor and growth-hormone secretagogue signaling, peptide-interaction studies, cellular assays, and preclinical endocrinology research.
Format: 20 mg combination vials with 3 mL vial capacity.
Available box combinations: 40 mg, 100 mg, and 200 mg.
Purity: 99.93% multi-vial purity.
Testing status: Independently tested; purity, endotoxin, and heavy-metals screenings passed.
Batch details: Manufacturer ID WF03; batch CJIP202605.
Important specification note: The supplied data does not identify the individual CJC-1295 no DAC-to-Ipamorelin quantity ratio.

Notice Component - Compact

Research Use Only. Not for use in diagnostic tests.

Before Ordering

Independent certificate details, manufacturer IDs, and batch IDs should be reviewed before purchase when available.
Order cancellations for full refunds are available before shipment; shipped orders cannot be cancelled or refunded.
For damaged or incorrect goods, photograph the outer packaging, inner packaging, and product labels, then email support within 48 hours of carrier delivery.

SKU: COMBO-VIAL-CJC-1295-10102 Category: Cellular repair

Buy CJC-1295 No DAC/Ipamorelin Combo Vial – Peptide Partners

Name: Buy CJC-1295/Ipamorelin | 99.93% | Peptide Partners
SKU: COMBO-VIAL-CJC-1295-10102
Availability: InStock

Product Overview & Specifications

The CJC-1295 no DAC/Ipamorelin Combo Vial is a combination research-peptide product supplied by Peptide Partners for in-vitro testing, laboratory experimentation, peptide-interaction studies, receptor pharmacology, and preclinical endocrinology research.

CJC-1295 no DAC is studied as a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is investigated as a growth-hormone secretagogue in experimental receptor and cell-signaling systems. A combination vial should not automatically be assumed to reproduce the conditions, proportions, stability, or findings of studies performed with either peptide separately.

The supplied product data confirms the combined vial format and multi-vial purity but does not specify the individual amount or ratio of CJC-1295 no DAC to Ipamorelin. Researchers should verify the applicable certificate of analysis, composition documentation, and batch information before beginning any experiment.

Product Specifications

Specification	Details
Product name	CJC-1295 No DAC/Ipamorelin Combo Vial
Product type	Combination research-peptide vial
Research components	CJC-1295 no DAC and Ipamorelin
Product format	20 mg combination vials
Vial size	20 mg
Vial capacity	3 mL
Available box combinations	40 mg, 100 mg, and 200 mg
Individual component ratio	Not provided in supplied product data
Multi-vial purity	99.93%
Independent testing	Yes
Endotoxin screening	Passed
Heavy-metals screening	Passed
Purity screening	Passed
Manufacturer ID	WF03
Batch ID	CJIP202605
Cost per milligram	$4.38–$5.50

The stated 99.93% purity is based on multi-vial testing. Researchers should review the batch-specific certificate of analysis and composition documentation before beginning any experiment.

Research Context

CJC-1295 No DAC Research Context

CJC-1295 no DAC is investigated as a synthetic GHRH analogue in receptor, peptide-stability, analytical-detection, and preclinical endocrinology research. Related studies have examined GHRH-receptor activity, peptide metabolism, mass-spectrometry detection, and modified GHRH constructs in laboratory and animal models.

Ipamorelin Research Context

Ipamorelin is studied in experimental research involving growth-hormone secretagogue receptor signaling, ligand activity, peptide pharmacology, and cellular response assays. Results from studies involving Ipamorelin alone should not automatically be attributed to the specific combination vial supplied here.

Combination-Formulation Considerations

The supplied product information does not include a published study evaluating this specific CJC-1295 no DAC/Ipamorelin combination vial. It also does not provide the individual component ratio, formulation details, compatibility data, stability data, or validated interaction profile for the combined material.

Researchers evaluating the combination should confirm the identity and relative content of each component and establish appropriate analytical controls under the intended laboratory conditions. Findings from studies of CJC-1295 no DAC or Ipamorelin alone should not be presented as findings for this combination product.

Standard Research Disclaimer

Research Use Only. Not for use in diagnostic tests.

This product is solely intended for research purposes as a chemical compound. It is designated exclusively for in-vitro testing and laboratory experimentation. All information provided about this product is educational and should be evaluated by appropriately qualified research personnel.

By law, bodily introduction of this product into humans or animals is strictly prohibited. This compound combination must not be used, administered, or represented as a drug, food, dietary supplement, cosmetic, diagnostic material, or medical treatment. It is not intended to diagnose, treat, cure, or prevent any disease. It should be handled only by licensed and qualified professionals in an appropriately equipped laboratory and in accordance with applicable laws, institutional procedures, and relevant safety requirements.

Storage Information

Storage

All of our manufacturing partners produce peptides using the Lyophilization (Freeze Drying) process, ensuring products maintain stability for shipping and storage for 12+ months.
In lyophilized form, they are shelf-stable for many weeks. However, for long-term storage, it is recommended to store them in the freezer.
We often hear concerns about the standard "discard after 28 days of first use" disclaimer. Don't worry, this has nothing to do with studies regarding the efficacy of specific peptides. 28 days is the FDA requirement for producers of multi-use vials to prove their bacteriostatic maintains efficacy. This minimum requirement becomes the de facto standard.
In our experience, if you use proper sterile procedures and refrigerated storage, you can continue sampling from the same reconstituted vial for 3+ months.

Combo Vial: CJC-1295 no DAC/Ipamorelin (20mg vials)

Buy CJC-1295 No DAC/Ipamorelin Combo Vial – Peptide Partners